COVID-19 News Updates

Please visit our information page for important information about appointments, visitor restrictions, and regular updates on the COVID-19 situation at Dartmouth-Hitchcock Health.

Heads Up: Coping through COVID-19

D-HH Launches Third Installment of its Virtual Roundtable Series as Effects of COVID-19 Pandemic Continue

“Heads Up: Coping Through COVID-19” is a pre-recorded series of virtual conversations featuring D-HH mental health experts, community partners and other experts offering information and tips for people of all ages

View story

D-HH Chief Clinical Officer Edward J. Merrens, MD

D-HH Continues to Adapt to Rapidly Changing Health Care Landscape as COVID-19 Pandemic Rages On

National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care

View story

Dartmouth-Hitchcock COVID-19 Video Update

As Delta Variant Surges, Dartmouth-Hitchcock Releases New COVID-19 Information Video Update

Michael S. Calderwood, MD, MPH, addresses variant, third doses vs. booster shots, travel and gathering tips, and why ivermectin isn’t an approved COVID-19 treatment

View story

Image of the Dartmouth-Hitchcock Medical Center dome

Dartmouth-Hitchcock Returns to More Restrictive Policies Due to Substantial Levels of State-Wide Community Transmission of COVID-19

Updated visitor policy and COVID-19 pre-admission testing procedures began Wednesday, August 25, 2021

View story

From left to right, Michael L. Whitfield, PhD, and Joel A. Lefferts, PhD, work in the lab.

Dartmouth-Hitchcock and Dartmouth’s Geisel School of Medicine Receive Grant to Monitor COVID-19 Variants in the Region

A team of researchers and clinicians at Geisel and DHMC has begun working together on a NIH grant to track the development and spread of COVID-19 variants in the Upper Valley.

View story

COVID-19 vaccine

D-HH Answers Questions about Third COVID-19 Vaccine Dose for Immunocompromised People

The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.

View story

CHaD update

CHaD Releases School Re-opening Guidance

As districts in New Hampshire and Vermont prepare to reopen schools for in-person learning in a few weeks, leadership from New Hampshire’s only children’s hospital, Children’s Hospital at Dartmouth-Hitchcock has released recommendations for schools.

View story

Nurse giving vaccination

Dartmouth-Hitchcock Health to Require COVID-19 Vaccinations for Employees in Effort to Protect Health of Community

Effective September 30, 2021, Dartmouth-Hitchcock Health (D-HH) will require COVID-19 vaccination of employees as a condition of employment.

View story

Joanne M. Conroy inside new photo

Joanne’s Journal Digest: Delta Variant, Masks and Continued Vaccine Hesitancy

DHMC Chief Quality Officer Michael Calderwood, MD, MPH, reviews what we know and don't know about the Delta variant and how we should protect ourselves. 

View story

Michael Calderwood, MD, MPH, chief quality officer at DHMC

D-H Infectious Disease Physician Provides Guidance on the COVID-19 Delta Variant

The Delta variant (B.1617.2), which originated in India, is now the dominant variant of COVID-19 in the United States, and is more transmissible than the original virus.

View story